Okabe S, Arai Y, Gotoh A. Correspondence to: "Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations", Curik N et al. Leukemia. 2024; 38: 1415-1418. Leukemia 2025 Feb 6. doi: 10.1038/s41375-025-02521.
PMID: 39915650